Reuters logo
BRIEF-DBV Technologies announces completion of enrollment of the realise study in peanut allergic children
March 10, 2017 / 7:08 AM / 8 months ago

BRIEF-DBV Technologies announces completion of enrollment of the realise study in peanut allergic children

March 10 (Reuters) - DBV Technologies Sa:

* Reg-DBV Technologies announces completion of enrollment of the realise study in peanut allergic children

* Higher-Than-Expected patient demand leads to increased randomization target

* Global PHASE III program results expected in second half 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below